Simulations Plus, Inc. (NASDAQ:SLP) – Analysts at Taglich Brothers increased their FY2019 earnings per share estimates for shares of Simulations Plus in a report released on Thursday, July 19th. Taglich Brothers analyst H. Halpern now anticipates that the technology company will earn $0.52 per share for the year, up from their previous estimate of $0.51.
Get Simulations Plus alerts:Several other equities analysts also recently issued reports on SLP. BidaskClub upgraded Simulations Plus from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, June 13th. Zacks Investment Research downgraded Simulations Plus from a “buy” rating to a “hold” rating in a research report on Friday, March 23rd. Finally, ValuEngine upgraded Simulations Plus from a “buy” rating to a “strong-buy” rating in a research report on Monday, May 14th.
Simulations Plus stock opened at $18.15 on Friday. The company has a market cap of $305.63 million, a P/E ratio of 53.24 and a beta of -0.60. Simulations Plus has a one year low of $13.38 and a one year high of $23.95.
Simulations Plus (NASDAQ:SLP) last posted its earnings results on Tuesday, July 10th. The technology company reported $0.13 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.12 by $0.01. The business had revenue of $8.55 million during the quarter, compared to the consensus estimate of $7.86 million. Simulations Plus had a return on equity of 25.65% and a net margin of 29.88%.
Institutional investors and hedge funds have recently modified their holdings of the business. TIAA FSB bought a new stake in shares of Simulations Plus during the second quarter worth $225,000. Bank of Montreal Can bought a new stake in shares of Simulations Plus during the second quarter worth $186,000. Campbell & CO Investment Adviser LLC bought a new stake in shares of Simulations Plus during the second quarter worth $507,000. Millennium Management LLC bought a new stake in shares of Simulations Plus during the first quarter worth $752,000. Finally, Ancora Advisors LLC raised its position in shares of Simulations Plus by 12.9% during the first quarter. Ancora Advisors LLC now owns 296,837 shares of the technology company’s stock worth $4,378,000 after acquiring an additional 33,925 shares during the last quarter. Hedge funds and other institutional investors own 35.13% of the company’s stock.
In other Simulations Plus news, Chairman Walter S. Woltosz sold 18,500 shares of Simulations Plus stock in a transaction on Tuesday, May 29th. The stock was sold at an average price of $19.27, for a total value of $356,495.00. Following the completion of the transaction, the chairman now owns 5,454,408 shares in the company, valued at approximately $105,106,442.16. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 33.45% of the company’s stock.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, August 2nd. Shareholders of record on Thursday, July 26th will be given a $0.06 dividend. The ex-dividend date is Wednesday, July 25th. This represents a $0.24 annualized dividend and a yield of 1.32%. Simulations Plus’s payout ratio is 70.59%.
Simulations Plus Company Profile
Simulations Plus, Inc develops drug discovery and development software for mechanistic modeling and simulation worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), and pharmacodynamics of drugs administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments, which measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments.
Featured Story: Should you buy a closed-end mutual fund?
No comments:
Post a Comment